THE CONTROVERSIAL ROLE OF BROMOCRIPTINE IN PARKINSONS-DISEASE

被引：9

作者：

HARDIE, RJ

LEES, AJ

STERN, GM

机构：

来源：

CLINICAL NEUROPHARMACOLOGY | 1985年 / 8卷 / 02期

关键词：

D O I：

10.1097/00002826-198506000-00004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：150 / 155

页数：6

相关论文

共 29 条

[21] BROMOCRIPTINE IN PARKINSONISM - LONG-TERM TREATMENT, DOSE-RESPONSE, AND COMPARISON WITH LEVODOPA
PARKES, JD
DEBONO, AG
MARSDEN, CD
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (11) : 1101 - 1108
[22] SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE IN THE TREATMENT OF PARKINSONS-DISEASE
RASCOL, A
MONTASTRUC, JL
RASCOL, O
[J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 229 - 232
[23] METABOLITE INVOLVEMENT IN BROMOCRIPTINE-INDUCED CIRCLING BEHAVIOR IN RODENTS
REAVILL, C
JENNER, P
MARSDEN, CD
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (04) : 278 - 284
[24] BROMOCRIPTIN IN THE TREATMENT OF PROGRESSIVE STAGES OF PARKINSONS-DISEASE
SCHNEIDER, E
FISCHER, PA
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (05) : 175 - &
[25] SEEMAN P, 1980, PHARMACOL REV, V32, P229
[26] SHAW KM, 1980, Q J MED, V49, P283
[27] DIFFERENTIAL EFFECTS OF 3 DOPAMINE AGONISTS - APOMORPHINE, BROMOCRIPTINE AND LERGOTRILE
SILBERGELD, EK
PFEIFFER, RF
[J]. JOURNAL OF NEUROCHEMISTRY, 1977, 28 (06) : 1323 - 1326
[28] BROMOCRIPTINE - LOW-DOSE THERAPY IN PARKINSON DISEASE
TEYCHENNE, PF
BERGSRUD, D
RACY, A
ELTON, RL
VERN, B
[J]. NEUROLOGY, 1982, 32 (06) : 577 - 583
[29] Yahr MD., 1976, ADV PARKINSONISM, P435